We are experiencing a very high volume of calls and messages and ask for your patience. We will answer your portal messages within 48 hours.
For more than a decade, we have been screening embryos for chromosomal number abnormalities (aneuploidy) at InVia Fertility Specialists. The technical term used for this process is preimplantation genetic screening (PGS) or pre-implantation genetic diagnosis (PGD). By screening out “abnormal” embryos we are now routinely able to achieve excellent pregnancy rates with transfer of single embryos and thus significantly reducing the incidence of multiple pregnancies. PGD or PGS, thus, is the smart thing to do so much that we have coined the term SMART IVF to describe them.
A common question we get asked about the process is, “How many normal (euploid) embryos will I produce?” Demko et al addressed this very issue in a recent publication. They analyzed the relationship between maternal age and the rate of embryos that tested as euploid, the average number and proportion of normal embryos per IVF cycle and the possibility of retrieving at least one normal embryo.
Results of Study on Age and Number of Eggs Obtained After Preimplantation Genetic Screening
The study analyzed more than 46,000 embryos between 2009 and 2014.
They concluded that (1) 33% to 50% of all embryos screened in women aged 18 to 48 years are aneuploid and (2) the number and percentage of euploid embryos decreases with advancing maternal age.
At InVia Fertility Specialists, we have been offering SMART IVF (PGD or PGS) for many years. Currently, using this technology, we are having pregnancy rates approximating 70% with the transfer of a single embryo.
To see a fertility specialist with a high success rate using single embryo transfer, make an appointment at one of InVia's four Chicago area fertility clinics.
Entire Website © 2003 - 2020
Karande and Associates d/b/a InVia
Fertility Specialists